Enteer™ Re-entry System
The Power of Control.
The Enteer™ Re-entry System consists of a catheter and guidewire, enabling the physician to reliably target the true lumen from the subintimal channel, above or below the knee. The catheter's unique, flat shape self-orients in the subintimal space, helping to enable re-entry without complete reliance on visualization.
- Angled re-entry probe at the guidewire tip engages the intima to enter true lumen
- Unique balloon shape self-orients within the vessel for true lumen targeting
- 180° opposed and offset exit ports enable selective guidewire re-entry
|Re-entry Catheter Specifications|
|Crossing Profile (max in)||0.066|
|Balloon Dimensions (mm) (width x height x length)||3.75 x 1.5 x 20||2.75 x 1.0 x 20|
|Working Device Length (cm)||135||150|
|Distal Coating||95 cm Hydrophilic|
|Guidewire Compatibility (in)||≤ 0.018|
|Enteer Guidwire Specifications|
|Tip Reach (mm)||1.5||1.5||2.5|
The Enteer™ Catheter is indicated for directing, steering, controlling and supporting a guidewire in order to access discrete regions of the peripheral vasculature. The Covidien Peripheral System is indicated for use to facilitate the intraluminal placement of conventional guidewires beyond stenotic peripheral lesions (including chronic total occlusions) prior to placement of other interventional devices. The Enteer™ Guidewire is intended to facilitate placement of balloon dilatation catheters or other intravascular devices during percutaneous transluminal angioplasty (PTA). The Enteer Guidewire is not to be used in cerebral blood vessels. The Covidien Peripheral System is indicated for use to facilitate the intraluminal placement of conventional guidewires beyond stenotic peripheral lesions (including chronic total occlusions) prior to placement of other interventional devices.
CAUTION: Federal (USA) law restricts these devices to sale by or on the order of a physician. Indications, contraindications, warnings and instructions for use can be found in the product labeling supplied with each device.